Literature DB >> 3498575

In vitro synthesis of IgE by human peripheral blood leucocytes: V. Functional heterogeneity within the IgE-B-cell pool.

K J Turner1, P G Holt, B J Holt, K J Cameron, J D Hobday, P Thompson, M Phillips.   

Abstract

Fractionation of human peripheral blood leucocytes (PBL) B cells by differential sedimentation on a discontinuous Percoll gradient separates B cell subpopulations which vary markedly in rates of spontaneous IgE synthesis, often revealing the presence of active IgE secreting cells which are totally suppressed within unfractionated PBL B cell preparations. The production in vitro of IgE by separated B cell populations from the same individual may respond disparately to an identical population of autologous T cells and to pokeweed mitogen. Kinetic studies revealed major differences in both the rates of release of cell-associated IgE between these B cell populations, and their rates of de novo IgE synthesis. From a methodological viewpoint, the use of this B cell fractionation technique is demonstrated to improve greatly the efficiency of detection of T cell-responsive IgE producing B cells in peripheral blood from atopics, and from a mechanistic standpoint raises the possibility that B cell heterogeneity may modulate the functional expression of IgE-regulatory T cells signals.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3498575      PMCID: PMC1542731     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  17 in total

1.  Twenty years with IgE: from the identification of IgE to regulatory factors for the IgE response.

Authors:  K Ishizaka
Journal:  J Immunol       Date:  1985-07       Impact factor: 5.422

2.  In vitro production of IgE by human peripheral blood mononuclear cells. I. Rate of IgE biosynthesis.

Authors:  S Romagnani; E Maggi; G F Del Prete; R Troncone; M Ricci
Journal:  Clin Exp Immunol       Date:  1980-10       Impact factor: 4.330

3.  In vitro synthesis of IgE by human peripheral blood leucocytes. IV. Longitudinal study of regulatory T-cell activity in atopics.

Authors:  K J Turner; P G Holt; J D Hobday; K J Cameron; B J Holt
Journal:  Int Arch Allergy Appl Immunol       Date:  1985

4.  Generation of IgE-binding and IgG-binding factors from human lymphoblastoid cell lines.

Authors:  J R Jensen; T T Sand; H L Spiegelberg
Journal:  Immunology       Date:  1984-09       Impact factor: 7.397

5.  In vitro synthesis of IgE by human peripheral blood leucocytes. II modulation of IgE B cell activity by isotype-specific regulatory T cells.

Authors:  G H Holt; K J Turner; B J Holt
Journal:  Clin Exp Immunol       Date:  1981-09       Impact factor: 4.330

6.  In vitro synthesis of IgE by human peripheral blood leucocytes. III. Release of pre-formed antibody.

Authors:  K J Turner; P G Holt; B J Holt; K J Cameron
Journal:  Clin Exp Immunol       Date:  1983-02       Impact factor: 4.330

7.  Induction of human IgE synthesis by a factor derived from T cells of patients with hyper-IgE states.

Authors:  J A Saryan; D Y Leung; R S Geha
Journal:  J Immunol       Date:  1983-01       Impact factor: 5.422

8.  In vitro synthesis of IgE by human peripheral blood leucocytes: relationship to serum titre of leucocyte donor.

Authors:  K J Turner; B J Holt; P G Holt
Journal:  Clin Exp Immunol       Date:  1981-03       Impact factor: 4.330

9.  Subpopulations of circulating B cells and regulatory T cells involved in in vitro immunoglobulin E production in atopic patients with elevted serum immunoglobulin E.

Authors:  A Saxon; C Morrow; R H Stevens
Journal:  J Clin Invest       Date:  1980-06       Impact factor: 14.808

10.  In vitro stimulation of IgE production at a single precursor level by human alloreactive T helper clones.

Authors:  A Lanzavecchia; B Parodi
Journal:  Clin Exp Immunol       Date:  1984-01       Impact factor: 4.330

View more
  1 in total

1.  Comparison of IgE expression at the mRNA and protein levels in vitro.

Authors:  K J Turner; J Creany; R J Coelen; K J Cameron; B J Holt; M W Beilharz
Journal:  Immunology       Date:  1991-12       Impact factor: 7.397

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.